一分钟看懂
这是一项关于晚期实体瘤的I 期研究，登记的药物或干预包括Drug: BG-T187；Other Therapeutic Agents，当前状态为招募中。登记地点显示中国北京、重庆、福州、广州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Drug: BG-T187；Other Therapeutic Agents · I 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Cancer Hospital Chinese Academy of Medical Sciences · 北京
- Chongqing University Cancer Hospital · 重庆
- Fujian Cancer Hospital · 福州
- Fujian Medical University Union Hospitalqishan Branch · 福州
- The Sixth Affiliated Hospital, Sun Yat Sen University · 广州
- Guangxi Medical University Cancer Hospital · 南宁
- The Fourth Hospital of Hebei Medical University · 石家庄
- Harbin Medical University Cancer Hospital · 哈尔滨
- Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology · 武汉
- Hubei Cancer Hospital · 武汉
- Hunan Cancer Hospital · 长沙
- The First Affiliated Hospital of Nanchang University Branch Xianghu · 南昌
- Liaoning Cancer Hospital and Institute · 沈阳
- Linyi Peoples Hospital · 临沂
- Affiliated Zhongshan Hospital of Fudan University · 上海
- Shanxi Provincial Cancer Hospital · 太原
- Tianjin Medical University Cancer Institute and Hospital · 天津
- Zhejiang Cancer Hospital · 杭州
- The First Affiliated Hospital, Zhejiang University School of Medicinezhijiang Branch · 杭州
公开的入选条件
- 1. Able to provide a signed and dated written informed consent prior to any study-specific procedures, sampling, or data collection.
- 2. Participants must be ≥ 18 years of age or the legal age of consent in the jurisdiction in which the study is taking place.
- 3. Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 1.
- 4. Participants with selected histologically or cytologically confirmed advanced, metastatic, and unresectable solid tumors who have been previously treated, including but not limited to non-small cell lung cancer (NSCLC), colorectal cancer (CRC).
- 5. ≥ 1 measurable or nonmeasurable lesion as assessed by RECIST v1.1. for Phase 1a Part A; ≥ 1 measurable lesion per RECIST v1.1. for Phase 1a Part B and Phase 1b.
- 6. Adequate organ function.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06598800；登记信息更新于 2026-09-11。